Cardiac Science Corporation (CSCX) - Financial and Strategic SWOT Analysis Review

Document Sample
Cardiac Science Corporation (CSCX) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					          Cardiac Science Corporation (CSCX) - Financial and Strategic SWOT
                                  Analysis Review

       Reference Code: GDME842FSA                                                                                      Publication Date: DEC 2010

       3303 Monte Villa Parkway            Phone            +1 425 4022000                             Revenue            156.9 (million USD)
       Bothell, WA                         Fax              +1 425 4022001                             Net Profit         -77 (million USD)
       98021                               Website          www.cardiacscience.com                     Employees          617
       United States                       Exchange         CSCX [NASDAQ]                              Industry           Medical Equipment

      Company Overview
       Cardiac Science Corporation (Cardiac Science) is engaged in the development, manufacture and marketing of diagnostic as well
       as therapeutic cardiology products and services. It provides an array of cardiology products designed to identify the early stages
       of heart disease, including electrocardiographs, cardiac stress testing systems, and holter monitors. The company operates in
       Europe, Asia, and the Americas. Cardiac Science markets its products in more than 100 countries worldwide.

      Key Executives                                                              SWOT Analysis
                     Name                                  Title                  Cardiac Science Corporation, SWOT Analysis
      Dr.    Ruediger         Naumann- Chairman                                   Strengths                    Weaknesses
      Etienne
                                                                                                                      Over-dependence on the US
      Dave Marver                          Chief Executive Officer                Strong Brand Image
                                                                                                                      Market
      W. Robert Berg                       Director
                                                                                  Innovation and Product
      Dr. Timothy C. Mickelson             Director                                                                   Declining Market Share in the
                                                                                  Development
                                                                                                                      Sector
      Christopher J. Davis                 Director
      Source: Annual Report, Company Website, Primary and Secondary Research,
      GlobalData

      Share Data                                                                  Opportunities                       Threats

      Cardiac Science Corporation                                                 Strategic Partnerships              Intense Competition
       Share Price (USD) as on 03-Dec-2010                                2.30
                                                                          -3.31   Increasing Cardiovascular           Cost Containment Pressures
       EPS (USD)
                                                                                  Diseases
       Market Cap (million USD)                                              55

       Enterprise Value (million USD)                                        50

       Shares Outstanding (million)                                          24   Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                  GlobalData
       Source: Annual Report, Company Website, Primary and Secondary Research,
       GlobalData

      Financial Performance                                                       Recent Developments
                                                                                  Nov 09, 2010         Cardiac Science Reports Total Revenues
                                                                                                       Of $34.48 Million For Q3 2010
                                                                                  Oct 19, 2010         Howard G. Smith Investigates Proposed
                                                                                                       Acquisition Of Cardiac Science By OCI
                                                                                  Jul 29, 2010         Cardiac Science Reports Revenues Of
                                                                                                       $36.10 Million In Q2 2010
                                                                                  Jul 27, 2010         Cardiac Science Unveils Two New Cardiac
                                                                                                       Stress Systems
                                                                                  Jul 19, 2010         Cardiac Science Addresses FDA Recall
                                                                                                       Concerns
       Source: Annual Report, Company Website, Primary and Secondary Research,    Source: Annual Report, Company Website, Primary and Secondary Research,
       GlobalData                                                                 GlobalData




Cardiac Science Corporation (CSCX) - Financial and Strategic SWOT Analysis                                                       Reference Code: GDME842FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                  Page 1
      Ta b le o f Co n te n ts
      Table of Contents ..................................................................................................................................................................................................... 2
      List of Tables ............................................................................................................................................................................................................ 4
      List of Figures ........................................................................................................................................................................................................... 4
      Section 1 - About the Company ................................................................................................................................................................................ 5
      Cardiac Science Corporation - Key Facts ................................................................................................................................................................. 5
      Cardiac Science Corporation - Key Employees ........................................................................................................................................................ 6
      Cardiac Science Corporation - Key Employee Biographies....................................................................................................................................... 7
      Cardiac Science Corporation - Major Products and Services .................................................................................................................................... 8
      Cardiac Science Corporation - History .....................................................................................................................................................................10
      Cardiac Science Corporation - Company Statement ................................................................................................................................................12
      Cardiac Science Corporation - Locations And Subsidiaries .....................................................................................................................................14
            Head Office .......................................................................................................................................................................................................14
            Other Locations & Subsidiaries .........................................................................................................................................................................14
      Cardiac Science Corporation - Key Manufacturing Facilities ....................................................................................................................................15
      Section 2 – Company Analysis ................................................................................................................................................................................16
      Cardiac Science Corporation - Business Description ...............................................................................................................................................16
            Business Description - Cardiac Monitoring Products .........................................................................................................................................16
                  Cardiac Monitoring Products - Overview .....................................................................................................................................................16
                  Cardiac Monitoring Products - Financials ....................................................................................................................................................16
                  Cardiac Monitoring Products - Market View ................................................................................................................................................16
                  Cardiac Monitoring Products - Key Strategies .............................................................................................................................................16
                  Cardiac Monitoring Products - Technology..................................................................................................................................................16
            Business Description - Defibrillation Products ...................................................................................................................................................16
                  Defibrillation Products - Overview ...............................................................................................................................................................17
                  Defibrillation Products - Financials ..............................................................................................................................................................17
                  Defibrillation Products - Market View...........................................................................................................................................................17
                  Defibrillation Products - Key Strategies .......................................................................................................................................................17
                  Defibrillation Products - Technology ............................................................................................................................................................17
            Business Description - Services ........................................................................................................................................................................17
                  Services - Overview ....................................................................................................................................................................................17
                  Services - Financials ...................................................................................................................................................................................17
      Cardiac Science Corporation - SWOT Analysis .......................................................................................................................................................18
            SWOT Analysis - Overview ...............................................................................................................................................................................18
            Cardiac Science Corporation - Strengths ..........................................................................................................................................................18
                  Strength - Strong Brand Image ...................................................................................................................................................................18
                  Strength - Innovation and Product Development .........................................................................................................................................18
                  Strength - Broad Range of Cardiology Products..........................................................................................................................................18
            Cardiac Science Corporation - Weaknesses .....................................................................................................................................................18
                  Weakness - Over-dependence on the US Market .......................................................................................................................................19
                  Weakness - Declining Market Share in the Sector ......................................................................................................................................19
                  Weakness - Weak Cost Management .........................................................................................................................................................19
                  Weakness - Principal Manufacturing Facility ...............................................................................................................................................19
            Cardiac Science Corporation - Opportunities.....................................................................................................................................................19
                  Opportunity - Strategic Partnerships ...........................................................................................................................................................19
                  Opportunity - Increasing Cardiovascular Diseases ......................................................................................................................................20
                  Opportunity - New Product Launches...........................................................................................................................
				
DOCUMENT INFO
Description: Cardiac Science Corporation (CSCX) - Financial and Strategic SWOT Analysis Review Summary Cardiac Science Corporation (Cardiac Science) is engaged in the development, manufacture and marketing of diagnostic as well as therapeutic cardiology products and services. It provides an array of cardiology products designed to identify the early stages of heart disease, including electrocardiographs, cardiac stress testing systems, and holter monitors. The company operates in Europe, Asia, and the Americas. Cardiac Science markets its products in more than 100 countries worldwide. Cardiac Science Corporation Key Recent Developments Nov 09, 2010 Cardiac Science Reports Total Revenues Of $34.48 Million For Q3 2010 Oct 19, 2010 Howard G. Smith Investigates Proposed Acquisition Of Cardiac Science By OCI Jul 29, 2010 Cardiac Science Reports Revenues Of $36.10 Million In Q2 2010 Jul 27, 2010 Cardiac Science Unveils Two New Cardiac Stress Systems Jul 19, 2010 Cardiac Science Addresses FDA Recall Concerns This comprehensive SWOT profile of Cardiac Science Corporation provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including, - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, se
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.